Study on prevalence of hepatitis B in pregnant women and its effect on maternal and fetal outcome at tertiary care centre

Sunita Mishra, Priyali Purandre, Ratna Thakur, Shweta Agrawal, Madhuri Alwani


Background: Hepatitis-B is caused by double stranded DNA virus. Prevalence of hepatitis B in pregnant woman worldwide is 2.5 to 1.5% whereas in India it is 2 to 7.7%.

Methods: This is a retrospective study conducted at SAMC and PGI, Indore between January 2016 to December 2016. Hepatitis- B prevalence and outcome was assessed by doing routine screening of hepatitis B antigen in our indoor patients and finding out their maternal and fetal outcome.

Results: Total 3567 deliveries were conducted during study period, out of them 39 were diagnosed as HbsAg positive pregnant patient; so, prevalence was found to be 1.09%. out of these, 84.6% were booked cases, mode of delivery was vaginal in 66.67% cases, preterm Delivery was in 10.26% of cases, meconium stained liquor was found in 5.13% cases, maternal mortality was nil, perinatal mortality was found in 2.56% cases and 5.13% cases were admitted in NICU.

Conclusions: Screening of all pregnant women for HbsAg irrespective of risk factors will definitely help to know the correct prevalence and reduce the transmission of hepatitis B infection. Hepatitis B is a major public health problem in India and will continue to be until appropriate nationwide vaccination programs and other control measures are established.


Hepatitis B surface antigen, Pregnant woman, Prevalence

Full Text:



Gukk HH, Majumdar PD, dhurinjiboy KR, Desai HG, prevalence of Hepatitis B, antigen in pregnant women and patients with liver disease. J Assoc. Physicians of India. 1995;43:247-48.

Kolawole OM, Wahab AA, Adekanle DA, Sibanda T, Okoh AI. Seroprevalence of hepatitis B surface antigenemia and its effects on hematological parameters in pregnant women in Osogbo, Nigeria. Virol J. 2012;9:317.

Jonas MM, Reddy RK, Demedina M, Sehiff ER. Hepatitis B infection in large municipal obstetric population: characterization and preventon of perinatal transmission Am J Gastroenterol. 1990;85:277.

Yang HI, Lu SN, Liaw YF, You SL, Sun CA, wang LY et al. Hepatitis B e antigen and the risk of hepatocellular carcinoma. N Engl J Med. 2002;347:168-174.

American college of Obstetricians and Gynecologists ACOG Practice Bulletin No.86: Viral hepatitis in pregnancy. Obstet Gynecol. 110:941-956.

Sheila S. Hepatitis B. in; Diseases of the liver and biliary system 10th Ed. Blackwell. 2001;272-6.

Chatterjee S, Ravishankar K, Chatterjee R, Narang A, Kinikar A. Hepatitis B Prevalence during pregnancy. Indian Pediatrics. 2009;46(11):1005-8.

André FE, Zuckerman AJ. Review: protective efficacy of hepatitis B vaccines in neonates. J Med Virol. 1994;44:144-51.

Lobste S, Faber R, Tillmann HL. Prevalence of hepatitis B among pregnant women and its impact on pregnancy and newborn complications at a tertiary hospital in the eastern part of Germany. Digestion. 2011;83:76-82.

Zali R, Mohammad K, Farhadi A, Masjedi MR, Zargar A and Nowroozi A. Epidemiology of hepatitis B in the IR of Iran. EMHJ. 1996;2(2):290-8.

Katke RD. The impact of maternal HbsAg carrier status on pregnancy outcomes: an institutional experience; Katke, Gynecol Obstet. (sunnyvale). 2015;5:5.

Afzali H, Heravi M, Moravveji SA, Poorrahnama M. Prevalence of Hepatitis B Surface Antigen in Pregnant Women in Beheshti Hospital of Kashan, Isfahan; Iranian Red crescent medical journal’ Rec. 2014;24.

Tse KY, Ho LF, Lao T. The impact of maternal HBsAg carrier status on pregnancy outcomes: a case-control study. J Hepatol. 2005;43:771-5.

Wong S, chan LY, Yu V, Ho L. Hepatitis B carrier and perinatal outcome in singleton pregnancy. Am J Perinatol. 2015;16:485-8.

Merat S, Malekzadeh R. Hepatitis B in Iran. Arc Irn Med J. 2003;4:192-201.